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Abstract
Background: Spotted fever caused spotted fever group rickettsiae (SFGR) is prevalent throughout China. In this
study, we describe a rapid, simple, and sensitive loop-mediated isothermal amplification (LAMP) assay targeting the
ompB gene of spotted fever group rickettsiae ideal for application in China. The LAMP assay has the potential to
detect spotted fever group rickettsiae early in infection and could therefore serve as an alternative to existing
methods.
Methods: A set of universal primers which are specific 7 common species of spotted fever group rickettsiae in China
were designed using PrimerExplorer V4 software based on conserved sequences of ompB gene. The sensitivity,
specificity and reproducibility of the LAMP were evaluated. The LAMP assay for detecting SFGR was compared with
conventional PCR assays for sensitivity and specificity in early phase blood samples obtained from 11 infected
human subjects.
Results: The sensitivity of the LAMP assay was five copies per reaction (25 μL total volume), and the assay did not
detect false-positive amplification across 42 strains of 27 members of the order Rickettsiales and 17 common clinical
pathogens. The LAMP assay was negative to typhus group rickettsiae including R. prowazekii and R. typhi for no
available conserved sequences of ompB was obtained for designing primers.
To evaluate the clinical applicability of the LAMP assay, a total of 11 clinical samples, 10 samples confirmed
serologically (3 cases), ecologically (1 case), by real-time polymerase chain reaction (PCR; 2 cases), ecologically and by
real-time PCR (1 case), and serologically and by real-time PCR (3 cases) were analyzed by the ompB LAMP assay. Data
were validated using a previously established nested PCR protocol and real-time PCR. A positive LAMP result was
obtained for 8 of the 10 confirmed cases (sensitivity, 73%; specificity, 100%), while none of these samples were
positive by nested PCR (sensitivity, 0%; specificity, 100%).
Conclusions: The LAMP assay described here is the most reliable among the three methods tested and would be
an ideal choice for development as a rapid and cost-effective means of detecting SFGR in China.
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Background
Spotted fever is caused by obligate (Gram-negative)
intracellular spotted fever group rickettsiae (SFGR) [1].
SFGR are widely distributed throughout the world, caus-
ing both emerging and re-emerging infectious diseases
[2,3]. People working in wild fields, including farm work-
ers, forest workers, field soldiers, and travelers, are the
main populations susceptible to SFGR infection. In 1984,
only five species of SFGR were confirmed as human
pathogens but that number has since risen to more than
ten, such us Rickettsia massiliae, R. raoultii, R. parkeri,
R. africae, R. felis, R. japonica, R. peacokii, R. helvetica,
R. montanensis, R. monacensis, R. rhipicephali. There are
three main pathogenic SFGR in China: R. sibirica [4], R.
heilongjiangensis [5], and R. sibirica mongolotimonae [6].
Unrecognized pathogens, combined with the lack of
a rapid and sensitive diagnostic method for identifying
SFGR, may be responsible for causing delayed treatment
or misdiagnosis that could lead to the development of
severe disease and fatality [7]. The greatest challenge to
clinicians is not therapy but the difficult diagnosis during
the early phase of infection. Conventional serodiagnosis
requires serum from both the acute and convalescent
stages of infection, the latter of which would be unavail-
able at early diagnosis. Although SFGR can be isolated
and reliably identified from samples cultivated in the
laboratory, this approach for early diagnoses also has its
drawbacks, as this method is generally associated with
low isolation rates and requires sophisticated and expen-
sive equipment. Other methods that have been applied
for this purpose, such as those involving the polymerase
chain reaction (PCR) (i.e., conventional, nested, and real-
time PCR), also require expensive, specialized instru-
ments those are not widely available.
Loop-mediated isothermal amplification (LAMP) is a
novel nucleic acid amplification method that was devel-
oped in 2000 [8]. LAMP is a highly sensitive, specific and
simple technique that under isothermal conditions (60-
65°C) can generate up to a 109-fold amplification in less
than an hour, making LAMP a rapid and simple diagnos-
tic tool for identifying SFGR. In this study, we aimed to
develop a rapid, sensitive and specific assay targeting the
ompB gene to detect SFGR infection in humans from
rural areas of China.
Methods
Clinical samples
Between 2007 and 2009, we obtained 11 samples from
clinical SFGR cases from four different hospitals (Peking
University First Hospital, Laizhou People’s Hospital,
Beijing Friendship Hospital, and 302 Military Hospital of
China). This study was approved by the Human Research
Ethics Committee of the Chinese Center for Disease
Control and Prevention (China CDC). Before entry into
the study, each patient was informed about the purpose
and procedures of the research and written consent was
obtained. Two milliliters of ethylenediaminetetraacetic
acid (EDTA)-anticoagulated blood and 2 mL of non-
anticoagulated blood were collected during the acute
phase of illness for culture and for the detection of
IgM and IgG antibodies, respectively. DNA was extracted
from the remaining clots for nested PCR [9], real-time
PCR [10], and the LAMP assay. A second serum sample
was collected during the convalescent stage (2-4 weeks
after acute phase) to detect IgG antibodies. Each case
was confirmed by indirect fluorescent antibody analysis
(IFA; four-fold increase or decrease in IgG antibody titer),
as recommended by the World Health Organization
(WHO), and the analysis of clinical criteria was able to
exclude other febrile illnesses [7,10-12]. All the patients
were eventually cured by administration of specific anti-
biotic therapy for rickettsiosis.
Laboratory strains
The specificity of the LAMP assay was determined using
a total of 42 strains of the order Rickettsiales (Table 1).
These strains were provided by Dr Raoult D from the
WHO Collaborating Centre for Rickettsial Reference
and Research (Marseille, France). Other common clinical
pathogenic bacteria were obtained from the relevant
department of the China CDC (Table 1). Genomic DNA
was extracted from cultured cells using the QIAamp
DNA Mini Kit (Qiagen, Hilden, Germany). In addition,
total blood DNA from healthy humans, cattle, horses,
goats, and mice was isolated for use as negative controls.
Before being used to determine the specificity of the
LAMP assay, each bacterial DNA sample was first pre-
screened by PCR using universal prokaryotic bacterial
16S rRNA primers, as previously described [13]. Gen-
omic DNA from the 42 strains was tested by LAMP to
determine the specificity of the ompB LAMP assay. All
detection assays were performed in triplicate.
LAMP primer design
A set of universal primers complementary to the ompB
of Rickettsia sp. BJ-90 (GenBank Accession: AY331393)
was designed using PrimerExplorer V4 software (http://
primerexplorer.jp; Eiken Chemical Co., Ltd., Tokyo,
Japan) based on conserved sequences determined by
the nucleotide alignment of 17 ompB GenBank entries
(Table 1). These primers were assumed to be specific for
SFGR since no available conserved sequences of the
ompB gene were found in the typhus group of rickettsiae,
such as R. prowazekii and R. typhi. The primers were
synthesized by Sangon Biotech (Shanghai, China). The
primer sequences and their positions relative to the ompB
gene are shown in Table 2 and Figure 1.
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Reference plasmid
To determine the sensitivity of the LAMP assay, a
recombinant plasmid containing the target sequence of
the Rickettsia sp. BJ-90 (GenBank Accession: AY331393)
ompB gene was constructed. The sequence located be-
tween the F3 and B3 primer binding sites was amplified
using primers OP1 (50-CACCGCCAGCGTTCCCTAT-30)
and OP2 (50-AACTGCTGAAATGGCTGGAC-30). The
resulting PCR products (624 bp) were cloned into
the pEASY-T1 vector using the pEASY-T1 Cloning Kit
(TransGen, China). The recombinant plasmid was quan-
tified by NanoPhotometer (Implen, Germany) and seri-
ally diluted (to concentrations of 55, 54, 53, 52, 51, and 50
copies/μL) to evaluate the limit of detection and reprodu-
cibility of the ompB LAMP assay.
LAMP reaction
All LAMP reactions were performed using the Loopamp
Kit (Eiken Chemical Co., Ltd., Tokyo, Japan) in a 25 μL
reaction volume containing 1.6 μM of each of the FIP
Table 1 Laboratory strains used for determining the specificity of the LAMP assay and aligned sequences for designing
primers
Members of the order Rickettsiales The related species Aligned sequences
Rickettsia prowazekii Bartonella henselae Astrakhan rickettsia (AF123708.1)
Rickettsia typhi Bartonella quintana Israeli tick typhus rickettsia (AF123712.1)
Orientia tsutsugamushi (types Karp, Kato and Gilliam) Rickettsia mongolotimonae (AF123715.1)
Anaplasma phagocytophilium strains Webster, MRK,
Slovienie and MD
Other common clinical pathogenic
bacteria
Rickettsia parkeri (AF123717.1)
Rickettsia sibirica Coxiella burnetii Rickettsia sp. S (AF123720.1)
Rickettsia conorii Borrelia burgdorferi (2)a Rickettsia conorii strain Seven (AF123721.1)
Rickettsia honei strain marmionii Escherichia coli (3)a Rickettsia sibirica (AF123722.1)
Rickettsia akari Vibrio cholerae Rickettsia conorii strain Indian tick typhus rickettsia
(AF123726.1)
Rickettsia rickettsii Bacillus anthracis Rickettsia heilongjiangensis (AY260451.1)
Rickettsia africa Haemophilus influenzae (2)a Rickettsia heilongjiangensis variant extremiorientalis
(AY280712.1)
Rickettsia parkeri Listeria spp. Rickettsia sp. BJ-90 outer (AY331393.1)
Rickettsia japonica Legionella spp. Rickettsia mongolotimonae isolate URRMTMFEe65
(DQ097083.1)
Rickettsia slovaca Yersinia pestis Rickettsia rickettsii strain Dv090589 (GU395293.1)
Rickettsia aeschlimannii Shigella dysenteriae (3)a Rickettsia sibirica strain RH05 (HM050273.1)
Rickettsia montanensis Neisseria meningitides Rickettsia rickettsii (X16353.1)
Rickettsia helvetica Leptospira spp. Rickettsia japonica (AB003681.1)






Note: a: The number in brackets indicates the number of the isolates used in the study.
Table 2 Nucleotide primer sets used for the ompB LAMP assay
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and BIP primers, 0.8 μM of the LF and LB primers,
0.2 μM of the F3 and B3 primers, 20 mM Tris–HCl
(pH 8.8), 10 mM KCl, 8 mM MgSO4, 10 mM (NH4)2SO4,
0.1% Tween-20, 0.8 M betaine, 1.4 mM of each deoxy-
nucleoside triphosphate (dNTP), and 1 μL Bst DNA
polymerase (8 U/μL). The reaction was incubated in a
real-time turbidimeter (model LA200, Teramecs, Tokyo,
Japan) at 63°C for 60 min and then at 80°C for 5 min to
terminate the reaction. Positive and negative samples
were distinguished by a turbidity cutoff value of 0.1. After
amplification, the LAMP products were examined by
electrophoresis on 2% agarose gels stained with ethidium
bromide or by visual inspection after the addition of 1 μL
of 1000× concentrated SYBR Green I.
Evaluation of the sensitivity, specificity, and
reproducibility of the LAMP assay
To compare the sensitivities of the ompB LAMP assay
and general PCR, the serially-diluted reference plasmid
(at concentrations of 55, 54, 53, 52, 51, and 50 copies/μL)
containing the target DNA was used to first define the
limit of detection. A general PCR using primers OP1 and
OP2 was performed as a 25 μL reaction containing 0.2 μM
of each primer, 0.4 mM of each dNTP, and 1 U of Taq
DNA polymerase. PCR was performed 35 times using a
denaturation step of 94°C for 50 s followed by annealing
at 52.5°C for 30 s and extension at 72°C for 45 s. The
PCR products were electrophoresed on a 1% TBE agarose
gel and stained with ethidium bromide (1 μg/mL).
To evaluate the reproducibility of the LAMP assay, the
serially-diluted reference plasmids were amplified in two
ways: five different times on the same day or once on each
of five consecutive days. The intra-assay coefficient of vari-
ation (CVi) and inter-assay coefficient of variation (CVo)
were analyzed at the time of peak precipitation, as deter-
mined using a real-time turbidimeter, as previously described
[14,15]. Statistical analysis was conducted using SAS soft-
ware (version 9.1; SAS Institute, Cary, NC).
Results
Specificity of LAMP
To determine the specificity of the LAMP assay for the de-
tection of SFGR, 27 members of the order Rickettsiales
were tested for amplification that included seven species of
the spotted fever group (R. sibirica, R. conorii, R. rickettsii,
R. africa, R. parkeri, R. japonicai, and R. heilongjiangensis).
All seven SFGR tested by this method were positive and
other common pathogens were not detected by LAMP.
These results indicate that the ompB LAMP assay was
specific for SFGR. The LAMP assay developed here did
not detect R. prowazekii and R. typhi even though both
possess an ompB gene but no conserved sequences where
primers were design are present in these bacteria.
Sensitivity of LAMP
The limits of detection of LAMP and PCR for the ompB
gene were 5 and 625 copies per reaction, respectively
(Figures 2 and 3). Thus, the LAMP assay is 125-fold sen-
sitive than conventional PCR for detecting SFGR.
Reproducibility of LAMP
The minimal detection levels, CVi and CVo, of the
LAMP assay were 1.58 and 3.11%, respectively (Table 3).
Examination of clinical samples
Of the 11 samples that were assayed, seven cases of
SFGR infection were confirmed in our laboratory. While
Figure 1 The rickettsial ompB gene indicating names and binding sites of primers for LAMP.
Figure 2 Comparison of the detection limit of LAMP and
general PCR, as observed after agarose gel electrophoresis.
Lane M, DNA marker; lanes 55, 54, 53, 52, 51, and 50 indicate the
number of gene copies/μL; lane N, negative control.
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one of the SFGR assignments was made by analysis
of bacterial cultures individually, the remaining three
were confirmed individually by IFA of acute- and
convalescent-phase serum samples, two were confirmed
individually by real-time PCR, one was confirmed by
both analysis of bacterial cultures and real-time PCR,
and three were confirmed by both IFA of acute- and
convalescent- phase serum samples and real-time PCR.
To evaluate the utility of LAMP for use with clinical
samples, the 11 samples analyzed by IFA were also sub-
jected to analysis by LAMP and nested PCR (Table 4).
Eight of the 10 confirmed cases of SFGR were positive by
the LAMP assay. In contrast, nested PCR did not yield
any positive identification.
Discussion
Although SFGR have been monitored in China for nearly
30 years, infection with SFGR remains widely undiag-
nosed, a problem that could be the cause of delays in
treatment or misdiagnoses that could lead to severe dis-
ease and fatal outcomes [3]. The WHO Collaborating
Centre for Rickettsial Reference and Research (Marseille,
France) regards the IFA as the “gold standard” for the
serological testing of rickettsial diseases. The drawback
of this method, however, is that it requires instrumen-
tation that is not common in rural areas. In China,
the availability of the non-specific Weill-Felix’s reaction
is limited to high-technology settings. However, this
method is no longer used as a routine screening method
for rickettsial diseases in developing countries. The
other drawback to serological assays is that it requires
convalescent-phase serum, a requirement that effectively
rules out its use for early diagnosis. Molecular diagnostic
techniques based on PCR have gradually replaced tedious
culture isolation methods for disease diagnosis. Modified
PCR techniques, such as nested PCR and real-time PCR,
do have their merits; however, these methods are com-
plicated and require a high-precision thermal cycler that
makes them impractical for the diagnosis of SFGR infec-
tions in rural areas.
In this study, we developed a sensitive LAMP assay
that detects a conserved region of the ompB gene; the
limit of detection of this assay was five copies per reac-
tion or twenty-fold lower than the detection limit for
the real-time PCR assay developed in our laboratory
(100 copies/reaction) (unpublished data). To evaluate the
LAMP assay as a tool for clinical diagnosis, we assayed
11 clinical samples by both LAMP and nested PCR. Of
the 11 samples, eight tested positive by the LAMP assay
with a limit of detection of five copies per reaction,
while none were positive by the nested PCR although the
limit of detection was 1 copy/μL. Previous studies have
described that the Bst polymerase used in LAMP is less
sensitive to inhibitors than Taq polymerase used in the
PCR assay [16-18]. Thus, although nested PCR has been
reported to be more sensitive for detecting SFGR than
the LAMP assay, we show in this study that the LAMP
assay is both more accurate and more sensitive than PCR
for screening clinical samples. It was notable; however,
Figure 3 Sensitivity of the LAMP assay as monitored by the real-time measurement of turbidity.
Table 3 Summary of the CVi and CVo of the time of peak
precipitation of serially-diluted plasmids





aIntra-assay coefficient of variation.
bInter-assay coefficient of variation.
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that one seropositive sample was not detected by ompB
LAMP. Because of these observations, we suggest that
SFGR infection be confirmed by more than one method
to prevent misdiagnosis. Three suspected cases of SFGR
were confirmed by LAMP but failed to score as positives
by IFA. We suspect that these differences may have
resulted from the failure of patients to develop sufficient
antibodies for individual differences to be revealed or sig-
nificant antibody titer during convalescence.
When evaluating the specificity of the ompB LAMP
assay, we tested 27 members of the order Rickettsiales
along with several other bacterial pathogens. The results
of this study showed that no false-positive amplification
was observed with the heterogeneous strains using the
SFGR LAMP assay and suggests that LAMP holds prom-
ise as an accurate method for differentiating between
SFGR and other diseases that cause similar symptoms.
The high specificity of LAMP methods has also been
reported for other pathogens [16,17,19-21]. Compared
with conventional PCR techniques that target between
two and four genomic regions, LAMP methods can
use between four and six primers to target six to
eight regions. Consistent with the work presented
here, researchers who study other pathogens have also
reported the high specificity of the LAMP assay. The
reproducibility of ompB LAMP is relatively high, in that
both the CVi and CVo are <5%. Although confirming
LAMP results by eye is important in low-technology
settings and could reduce amplicon carryover leading
to false-positive results, this method was less sensitive
than agarose gel electrophoresis in our study (data not
shown), as well as in others [18]. This result is in contrast
to the findings of Mao et al. [22], which demonstrated
that the two methods yielded consistent results. One
concern with the SYBR Green method, however, is the
risk of contamination that results from opening the tubes
to add reagents. We therefore consider it important to
take this risk into consideration when debating how to
reduce false-positive results during field testing.
In this study, we detected SFGR DNA in samples
extracted from whole blood using the LAMP assay, a
kit-based assay that is considered more sensitive than
freeze-thaw procedures. The problem of using such a kit,
however, is that it would increase the assay cost and
turn-around time. In support of using freeze-heat pro-
cedures, Paris et al. [19] were able to detect Orientia
tsutsugamushi (order Rickettsiales) in DNA samples
extracted using either a kit or by freeze-thaw procedures,
where 7 out of 7 and 5 out of 7 samples were confirmed
by these methods, respectively. Although the kit-based
method identified SFGR with a 100% success rate, we feel
that the use of boiled samples in the LAMP assay should
be reconsidered for greater suitability for use in rural
areas.
Conclusions
A rapid, simple, sensitive, and cost-effective LAMP assay
was developed for detecting SFGR in clinical samples.
Since the LAMP assay is a fast and sensitive method for
testing clinical samples without the aid of sophisticated
equipment or complicated operation, this method has
the potential to be a powerful tool supporting the diag-
nosis of SFGR in of China.
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Table 4 Comparison of the LAMP assay with nested PCR assay for the detection of the spotted fever rickettsiae group
in clinical samplesa
No. of cases Diagnosis type LAMP Nested PCR Real-time PCR
1 gltA gene amplified Pos. Neg. Pos.
2 gltA gene amplified Pos. Neg. Pos.
3 4-fold IgG titer increase Pos. Neg. Neg.
4 Culture confirmed and gltA gene amplified Pos. Neg. Pos.
5 4-fold IgG titer increase Pos. Neg. Neg.
6 4-fold IgG titer increase and gltA gene amplified Pos. Neg. Pos.
7 4-fold IgG titer increase and gltA gene amplified Pos. Neg. Pos.
8 Suspected case Neg. Neg. Pos.
9 Culture confirmed Neg. Neg. Neg.
10 4-fold IgG titer increase Neg. Neg. Neg.
11 4-fold IgG titer increase and gltA gene amplified Pos. Neg. Pos.
a All assays were performed in triplicate.
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